Seer (NASDAQ:SEER – Get Rating) and Illumina (NASDAQ:ILMN – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Analyst Ratings This is a breakdown of recent ratings and target prices […]
/PRNewswire/ Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has announced that Discovery Genomics is the first commercial.
Operator: Thank you for standing by and welcome to the Seer Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
/PRNewswire/ Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market (5th Edition), 2022-2035" report to its list of offerings..
ALAMEDA, Calif., Feb. 22, 2023 /PRNewswire/ AllCells®, a Discovery Life Sciences company and leading provider of critical starting material and services for cell and gene therapy (CGT), has